Literature DB >> 9446068

[Acute hepatitis following amiodarone administration].

E Tagliamonte1, G Cice, V Ducceschi, M S Mayer, A Iacono.   

Abstract

A 61 year old man, treated with amiodarone since 1993 for resistant supraventricular arrhythmias, developed acute hepatitis after an intravenous amiodarone administration. Kidney and liver function tests were performed and pointed out abnormal results. Symptoms ascribable to hepatotoxicity were absent. These changes returned to normal levels within 20 days from withdrawal of the drug. Amiodarone hepatotoxicity can be related to prolonged therapy with a high dose. Intravenous amiodarone may cause acute hepatic disease, but it is suggested that polysorbate 80, a solvent added to the intravenous infusion, is a more likely cause of this complication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9446068

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  2 in total

Review 1.  Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.

Authors:  Hugo Van Herendael; Paul Dorian
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

2.  Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature.

Authors:  Mohammad Nasser; Timothy R Larsen; Barryton Waanbah; Ibrahim Sidiqi; Peter A McCullough
Journal:  Drug Healthc Patient Saf       Date:  2013-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.